Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine Triple Therapy for H. pylori Eradication
NCT06514274Phase 4Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Sep 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of berberine in Helicobacter pylori infection, sponsored by Xijing Hospital of Digestive Diseases. Started Sep 2024; status: completed.
02
Drugs
berberine
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06514274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06514274.